In conclusion, in vitro and in vivo assays showed that FA-CD-PLLD/DOC/MMP-9 as the co-delivery of hydrophobic drug and gene can efficiently exert targeted anti-tumor effect. The gene discussed is MMP9; the disease is neoplasm.